Cormorant Pharmaceuticals - Articles and news items

Bristol-Myers Squibb acquires Cormorant Pharmaceuticals

Industry news / 5 July 2016 / Victoria White, Digital Content Producer

The acquisition gives Bristol-Myers Squibb full rights to Cormorant Pharmaceuticals’ HuMax-IL8 antibody programme…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+